Toxins 101 Workshop
A Basic Course on the Clinical Applications of Botulinum Neurotoxin
Registration for Toxins 101 will open December 1st. All registered attendees will receive an email with a link to register for this workshop. Note that the class size is limited.
This is a four-hour educational event designed as an overview of the use of botulinum neurotoxin in clinical practice. The target audience is clinicians (including those in training) who have relatively limited experience with botulinum neurotoxin, as well as interested basic scientists. This is an introductory program to provide basic knowledge of the clinical uses of botulinum neurotoxin. This course will provide a foundation of knowledge for more in-depth sessions to be held during the TOXINS 2026 main program. It is designed to allow those attending an insight into the principles of patient assessment, decision-making, and treatment approaches in managing people with a range of disabling conditions using botulinum neurotoxin. The course will focus on common disorders that are treated with botulinum neurotoxin.
The program will include didactic presentations, case histories, and videos. It will focus on practical issues, such as diagnosis, muscle selection and injection, determination of botulinum neurotoxin dosages, and recognition and management of adverse effects. It will provide ample opportunity for participant interaction.
Wednesday, 14 January, 2026
| 12:00 – 12:10 | Welcome and Introduction: The Diverse Clinical Uses of Botulinum Neurotoxins Jörg Wissel (Germany) & Anthony Ward (UK) |
| 12:10 – 12:40 | Botulinum Neurotoxins: Serotypes and Mechanism of Action Giampietro Schiavo (UK) |
| 12:40 – 13:05 | Botulinum Neurotoxin for the Treatment of Spasticity in Adults and Children Anthony Ward (UK) |
| 13:05 – 13:30 | Patient-centric Care: Optimizing Outcomes in the Management of Patients with Spasticity Jorge Jacinto (Portugal) |
| 13:30 – 14:00 | Botulinum Neurotoxin for the Treatment of Cervical Dystonia Hyder (Buz) Jinnah (USA) |
| 14:00 – 14:20 | Break |
| 14:20 – 14:50 |
Botulinum Neurotoxin for the Treatment of Other Movement Disorders |
| 14:50 – 15:05 | Self-Assessment: Clinical Quiz Anthony Ward (UK) |
| 15:05 – 16:00 |
Patient Cases: Management of Dystonia and Spasticity with BoNT-A Delegates to divide into groups for developing treatment programs |